AbitibiBowater Announces New Board of Directors for Restructured Company
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
Sarah Nash (New York, NY) is a board member and head of the Audit Committee of Merrimack Pharmaceuticals and director of Knoll Inc., where she serves on the Compensation and Audit Committees. Ms. Nash is also a director of Blackbaud, Inc. and serves on its Nominating and Governance Committee. In August 2005, Ms. Nash retired as Vice Chairman of J.P. Morgan Chase & Co.'s Investment Bank, where she was responsible for many of the firm's client relationships. Prior to these responsibilities, Ms. Nash was the Regional Executive and Co-Head of Investment Banking for North America.
0 Comments
View Comments
- Companies:
- AbitibiBowater Inc.
Related Content
Comments